Alexandra Krog

Alexandra Krog is a seasoned professional in the pharmaceutical and biotechnology industries, currently serving as Senior Director for CMC Portfolio Proteins, ADCs & Chemical Entities at BioNTech SE since May 2023. Prior to this role, Alexandra held various leadership positions at Merck Life Science, including R&D Program Manager for mRNA Solutions and Senior Biotech CMC Program Lead for late-phase biotech programs. Alexandra has extensive experience in CMC strategy development, budget management, and cross-functional collaboration, having led teams in the development of innovative drug formulations and analytical infrastructures. With a PhD in Pharmacy from Goethe University Frankfurt and early career experience at Novartis, Sanofi, and Aventis, Alexandra brings a robust background in molecular biology and biotechnology to the field.